Djamila E. Issa

Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis

Massimo Federico, María Dolores Caballero Barrigón, Luigi Marcheselli et al. · The Lancet Haematology · 2018 · 112 citations · Full text

Lymphoid Neoplasia, Medicine, Immunology +5

A high level of fatigue among long-term survivors of non-Hodgkin's lymphoma: results from the longitudinal population-based PROFILES registry in the south of the Netherlands

Simone Oerlemans, Floortje Mols, Djamila E. Issa et al. · Haematologica · 2012 · 90 citations · Full text

First-line venetoclax combinations versus chemoimmunotherapy in fit patients with chronic lymphocytic leukaemia (GAIA/CLL13): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial

Moritz Fürstenau, Arnon P. Kater, Sandra Robrecht et al. · The Lancet Oncology · 2024 · 59 citations · Full text

Trends in incidence, treatment and survival of aggressive B-cell lymphoma in the Netherlands 1989-2010

Djamila E. Issa, S.A.M. van de Schans, Martine E.D. Chamuleau et al. · Haematologica · 2014 · 57 citations · Full text

Health-related quality of life and persistent symptoms in relation to (R-)CHOP14, (R-)CHOP21, and other therapies among patients with diffuse large B-cell lymphoma: results of the population-based PHAROS-registry

Simone Oerlemans, Djamila E. Issa, Esther C. van den Broek et al. · Annals of Hematology · 2014 · 48 citations

Hematological Malignancy, Lymphoid Neoplasia, Health-related Quality +7